Europe Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Sclerotherapy Market would witness market growth of 7.5% CAGR during the forecast period (2020-2026).
Sclerotherapy is a medical procedure that is used to treat blood vessel or vascular deformities and also any malformations of the lymphatic system. In this procedure, medicine is introduced into the vessels, which results in their shrinking. It is used to treat vascular or lymphatic malformations in children and young adults. In adults, sclerotherapy is also used to treat spider veins, haemorrhoids, and smaller varicose veins.
This condition is beneficial and can be used to treatment by a dermatologist where an irritating medication is introduced into the vein to causes inflammation, fibrosis, endothelial damage, occlusion, and eventually overall absorption of the smaller vessels. In developed countries, about 30.0% of women and 10.0% of men consult the doctor for venous insufficiency signs and symptoms. Various factors like excess weight, heredity, and some professions that require prolonged period of sitting that may increase the risk of chronic venous disease of the legs. Long term thrombosis and varicose veins results in skin pigmentation, skin lesions, dermatitis, eczema, chronic edema, and ulcer.
The attention of both doctors and patients has been shifted towards less-invasive treatment procedures, availability of advanced treatment devices for varicose vein, as well as huge burden of varicose vein cases are the main driving factors in the growth of the market. Other factors include improvement in patient reliability and compliance, increasing healthcare expenditure, and swift growth in aging population.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the Study
Market Segmentation:
By Agent
Sclerotherapy is a medical procedure that is used to treat blood vessel or vascular deformities and also any malformations of the lymphatic system. In this procedure, medicine is introduced into the vessels, which results in their shrinking. It is used to treat vascular or lymphatic malformations in children and young adults. In adults, sclerotherapy is also used to treat spider veins, haemorrhoids, and smaller varicose veins.
This condition is beneficial and can be used to treatment by a dermatologist where an irritating medication is introduced into the vein to causes inflammation, fibrosis, endothelial damage, occlusion, and eventually overall absorption of the smaller vessels. In developed countries, about 30.0% of women and 10.0% of men consult the doctor for venous insufficiency signs and symptoms. Various factors like excess weight, heredity, and some professions that require prolonged period of sitting that may increase the risk of chronic venous disease of the legs. Long term thrombosis and varicose veins results in skin pigmentation, skin lesions, dermatitis, eczema, chronic edema, and ulcer.
The attention of both doctors and patients has been shifted towards less-invasive treatment procedures, availability of advanced treatment devices for varicose vein, as well as huge burden of varicose vein cases are the main driving factors in the growth of the market. Other factors include improvement in patient reliability and compliance, increasing healthcare expenditure, and swift growth in aging population.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the Study
Market Segmentation:
By Agent
- Detergents
- Osmotic Agents
- Chemical Irritants
- Liquid Sclerotherapy
- Ultrasound Sclerotherapy
- Foam Sclerotherapy
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Boston Scientific Corporation
- Perrigo Company PLC (Omega Pharmaceuticals)
- Cook Medical, Inc. (Cook Group)
- Chemische Fabrik Kreussler & Co. GmbH
- LGM Pharma, LLC
- Troikaa Pharmaceuticals Limited
- Tianyu Chang’an Group
- Endo-Flex GmbH (Meditek Systems)
- Merz Pharma GmbH & Co. KGaA
- MTW-Endoskopie W. Haag KG
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sclerotherapy Market, by Agent
1.4.2 Europe Sclerotherapy Market, by Type
1.4.3 Europe Sclerotherapy Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE SCLEROTHERAPY MARKET BY AGENT
3.1 Europe Detergents Market by Country
3.2 Europe Osmotic Agents Market by Country
3.3 Europe Chemical Irritants Market by Country
CHAPTER 4. EUROPE SCLEROTHERAPY MARKET BY TYPE
4.1 Europe Liquid Sclerotherapy Market by Country
4.2 Europe Ultrasound Sclerotherapy Market by Country
4.3 Europe Other Type Market by Country
CHAPTER 5. EUROPE SCLEROTHERAPY MARKET BY COUNTRY
5.1 Germany Sclerotherapy Market
5.1.1 Germany Sclerotherapy Market by Agent
5.1.2 Germany Sclerotherapy Market by Type
5.2 UK Sclerotherapy Market
5.2.1 UK Sclerotherapy Market by Agent
5.2.2 UK Sclerotherapy Market by Type
5.3 France Sclerotherapy Market
5.3.1 France Sclerotherapy Market by Agent
5.3.2 France Sclerotherapy Market by Type
5.4 Russia Sclerotherapy Market
5.4.1 Russia Sclerotherapy Market by Agent
5.4.2 Russia Sclerotherapy Market by Type
5.5 Spain Sclerotherapy Market
5.5.1 Spain Sclerotherapy Market by Agent
5.5.2 Spain Sclerotherapy Market by Type
5.6 Italy Sclerotherapy Market
5.6.1 Italy Sclerotherapy Market by Agent
5.6.2 Italy Sclerotherapy Market by Type
5.7 Rest of Europe Sclerotherapy Market
5.7.1 Rest of Europe Sclerotherapy Market by Agent
5.7.2 Rest of Europe Sclerotherapy Market by Type
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sclerotherapy Market, by Agent
1.4.2 Europe Sclerotherapy Market, by Type
1.4.3 Europe Sclerotherapy Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE SCLEROTHERAPY MARKET BY AGENT
3.1 Europe Detergents Market by Country
3.2 Europe Osmotic Agents Market by Country
3.3 Europe Chemical Irritants Market by Country
CHAPTER 4. EUROPE SCLEROTHERAPY MARKET BY TYPE
4.1 Europe Liquid Sclerotherapy Market by Country
4.2 Europe Ultrasound Sclerotherapy Market by Country
4.3 Europe Other Type Market by Country
CHAPTER 5. EUROPE SCLEROTHERAPY MARKET BY COUNTRY
5.1 Germany Sclerotherapy Market
5.1.1 Germany Sclerotherapy Market by Agent
5.1.2 Germany Sclerotherapy Market by Type
5.2 UK Sclerotherapy Market
5.2.1 UK Sclerotherapy Market by Agent
5.2.2 UK Sclerotherapy Market by Type
5.3 France Sclerotherapy Market
5.3.1 France Sclerotherapy Market by Agent
5.3.2 France Sclerotherapy Market by Type
5.4 Russia Sclerotherapy Market
5.4.1 Russia Sclerotherapy Market by Agent
5.4.2 Russia Sclerotherapy Market by Type
5.5 Spain Sclerotherapy Market
5.5.1 Spain Sclerotherapy Market by Agent
5.5.2 Spain Sclerotherapy Market by Type
5.6 Italy Sclerotherapy Market
5.6.1 Italy Sclerotherapy Market by Agent
5.6.2 Italy Sclerotherapy Market by Type
5.7 Rest of Europe Sclerotherapy Market
5.7.1 Rest of Europe Sclerotherapy Market by Agent
5.7.2 Rest of Europe Sclerotherapy Market by Type
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 EUROPE DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 GERMANY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 GERMANY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 26 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 27 UK SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 28 UK SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 29 UK SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 30 UK SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 31 UK SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 UK SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 FRANCE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 34 FRANCE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 35 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 36 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 37 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 38 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 39 RUSSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 40 RUSSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 41 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 42 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 45 SPAIN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SPAIN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 48 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 49 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 50 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 51 ITALY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 52 ITALY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 53 ITALY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 54 ITALY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 55 ITALY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 56 ITALY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 57 REST OF EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 62 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 64 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 65 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 66 KEY INFORMATION – CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 67 KEY INFORMATION – LGM PHARMA, LLC
TABLE 68 KEY INFORMATION – TROIKAA PHARMACEUTICALS LIMITED
TABLE 69 KEY INFORMATION – TIANYU CHANG’AN GROUP
TABLE 70 KEY INFORMATION –ENDO-FLEX GMBH
TABLE 71 KEY INFORMATION – MERZ PHARMA GMBH & CO. KGAA
TABLE 72 KEY INFORMATION – MTW-ENDOSKOPIE W. HAAG KG
TABLE 1 EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 EUROPE DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 GERMANY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 GERMANY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 26 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 27 UK SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 28 UK SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 29 UK SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 30 UK SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 31 UK SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 UK SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 FRANCE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 34 FRANCE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 35 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 36 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 37 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 38 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 39 RUSSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 40 RUSSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 41 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 42 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 45 SPAIN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SPAIN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 48 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 49 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 50 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 51 ITALY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 52 ITALY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 53 ITALY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 54 ITALY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 55 ITALY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 56 ITALY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 57 REST OF EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 62 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 64 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 65 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 66 KEY INFORMATION – CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 67 KEY INFORMATION – LGM PHARMA, LLC
TABLE 68 KEY INFORMATION – TROIKAA PHARMACEUTICALS LIMITED
TABLE 69 KEY INFORMATION – TIANYU CHANG’AN GROUP
TABLE 70 KEY INFORMATION –ENDO-FLEX GMBH
TABLE 71 KEY INFORMATION – MERZ PHARMA GMBH & CO. KGAA
TABLE 72 KEY INFORMATION – MTW-ENDOSKOPIE W. HAAG KG
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
